HealthMore in Health→
Early Tirzepatide Analysis Raises New Questions About Lean Mass Loss in Obesity Treatment
Key Takeaways
- A preliminary study suggests tirzepatide may cause greater lean body mass loss than semaglutide.
- The same report says tirzepatide still helps patients lose more overall weight.
- Because the study is awaiting peer review, the finding should be treated as provisional.
- The result highlights growing clinical focus on body composition, not just total weight loss.
DE
DT Editorial Team··via endpoints.news